tradingkey.logo

Champions Oncology Inc

CSBR
7.220USD
0.000
收盘 12/19, 16:00美东报价延迟15分钟
99.55M总市值
33.44市盈率 TTM

Champions Oncology Inc

7.220
0.000

关于 Champions Oncology Inc 公司

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Champions Oncology Inc简介

公司代码CSBR
公司名称Champions Oncology Inc
上市日期Nov 30, 1988
CEOBrainin (Robert)
员工数量213
证券类型Ordinary Share
年结日Nov 30
公司地址One University Plaza,
城市HACKENSACK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07601
电话12018088400
网址https://championsoncology.com
公司代码CSBR
上市日期Nov 30, 1988
CEOBrainin (Robert)

Champions Oncology Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+9.81%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+77.99%
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+9.81%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+77.99%
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--

收入明细

FY2026Q1
FY2025
FY2025Q3
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
13.99M
0.00%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
Battery Management Corp
17.44%
New Enterprise Associates (NEA)
12.34%
Ackerman (Joel)
7.61%
West Elk Capital, LLC
6.36%
Morris (Ronnie)
6.19%
其他
50.07%
持股股东
持股股东
占比
Battery Management Corp
17.44%
New Enterprise Associates (NEA)
12.34%
Ackerman (Joel)
7.61%
West Elk Capital, LLC
6.36%
Morris (Ronnie)
6.19%
其他
50.07%
股东类型
持股股东
占比
Individual Investor
26.67%
Investment Advisor
23.00%
Venture Capital
12.34%
Hedge Fund
7.84%
Investment Advisor/Hedge Fund
3.88%
Research Firm
0.20%
其他
26.06%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
61
6.56M
52.08%
--
2025Q3
62
6.56M
52.44%
-79.02K
2025Q2
63
6.67M
52.80%
-161.89K
2025Q1
63
6.82M
51.27%
-269.97K
2024Q4
54
6.61M
53.30%
-64.85K
2024Q3
52
6.72M
54.61%
-200.66K
2024Q2
56
5.89M
46.40%
+140.55K
2024Q1
56
5.75M
45.40%
-421.54K
2023Q4
54
5.73M
45.75%
-128.46K
2023Q3
60
6.95M
52.42%
-72.37K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Battery Management Corp
2.40M
17.39%
-23.97K
-0.99%
Aug 22, 2025
New Enterprise Associates (NEA)
1.71M
12.43%
--
--
Jun 30, 2025
Ackerman (Joel)
962.13K
6.98%
--
--
Aug 22, 2025
West Elk Capital, LLC
882.58K
6.4%
-210.81K
-19.28%
Sep 30, 2024
Morris (Ronnie)
858.88K
6.23%
--
--
Aug 22, 2025
Sidransky (David)
767.04K
5.56%
--
--
Aug 22, 2025
Pessin (Norman H)
742.16K
5.38%
--
--
Aug 22, 2025
The Vanguard Group, Inc.
327.03K
2.37%
+19.16K
+6.22%
Jun 30, 2025
Tocqueville Asset Management LP
399.88K
2.9%
--
--
Jun 30, 2025
Mendelson (Daniel Newman)
198.63K
1.44%
--
--
Aug 22, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
占比0.01%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Champions Oncology Inc的前五大股东是谁?

Champions Oncology Inc 的前五大股东如下:
Battery Management Corp持有股份:2.40M,占总股份比例:17.39%。
New Enterprise Associates (NEA)持有股份:1.71M,占总股份比例:12.43%。
Ackerman (Joel)持有股份:962.13K,占总股份比例:6.98%。
West Elk Capital, LLC持有股份:882.58K,占总股份比例:6.40%。
Morris (Ronnie)持有股份:858.88K,占总股份比例:6.23%。

Champions Oncology Inc的前三大股东类型是什么?

Champions Oncology Inc 的前三大股东类型分别是:
Battery Management Corp
New Enterprise Associates (NEA)
Ackerman (Joel)

有多少机构持有Champions Oncology Inc(CSBR)的股份?

截至2025Q4,共有61家机构持有Champions Oncology Inc的股份,合计持有的股份价值约为6.56M,占公司总股份的52.08%。与2025Q3相比,机构持股有所增加,增幅为-0.35%。

哪个业务部门对Champions Oncology Inc的收入贡献最大?

在FY2026Q1,--业务部门对Champions Oncology Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI